Kollins John A 4
4 · Transcept Pharmaceuticals Inc · Filed Jun 21, 2012
Insider Transaction Report
Form 4
Kollins John A
SVP, Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2012-06-20+85,000→ 85,000 totalExercise: $6.11Exp: 2022-06-20→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the options vest on June 1, 2013 and one forty-eighth of the shares shall vest monthly thereafter.